Latest Breaking News On - New inhibrx - Page 1 : comparemela.com

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Ukraine
Inhibrx-biosciences-inc
Exchange-commission
Inhibrx-inc
Nasdaq
Securities-exchange
Inhibrx-biosciences
Current-report
New-inhibrx
Nasdaq-global-market
Securities-exchange-act

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

/PRNewswire/ Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with three clinical programs in development and a strong.

Ukraine
Jon-faiz-kayyem
Kimberly-manhard
Douglas-forsyth
Securities-exchange
Aventis-inc
Inhibrx-inc
Party-transactions
Company-on
Inhibrx-biosciences-inc
Nasdaq
Prnewswire-inhibrx-inc

Sanofi bets $1.7b on potential best-in-class rare disease therapy

Sanofi bets $1.7b on potential best-in-class rare disease therapy
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Phouman-ashrafian
Head-of-research
Inhibrx-inc
New-inhibrx

Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline -January 23, 2024 at 01:31 am EST

Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline Acquisition supports Sanofi’s portfolio growth.

Paris
France-general
France
Timothy-gilbert
Sally-bain
Eva-schaefer-jansen
Tarik-elgoutni
Sandrine-guendoul
Corentine-driancourt
Markp-lappe
Felix-lauscher
Nathalie-pham

France's Sanofi to buy U.S. drugs project INBRX-101 for around $2.2 bln

French healthcare company Sanofi has agreed to buy the drug development project INBRX-101 from its parent company Inhibrx Inc for around $2.2 billion, the companies said on Tuesday. As.

Paris
France-general
France
French
Christian-schmollinger
Sudip-kar-gupta
Reuters
Inhibrx-inc
New-inhibrx
Markets